MicroRNA-145 regulates the proliferation, migration and invasion of human primary colon adenocarcinoma cells by targeting MAPK1

Yang,Yong; Li,Xiao‑Jia; Li,Peng; Guo,Xiu‑Tian

doi:10.3892/ijmm.2018.3904

MicroRNA-145 regulates the proliferation, migration and invasion of human primary colon adenocarcinoma cells by targeting MAPK1

Authors:
- Yong Yang
- Xiao‑Jia Li
- Peng Li
- Xiu‑Tian Guo
View Affiliations

Affiliations: Department of Anus and Intestine, Shanghai Hospital of Traditional Chinese Medicine, Shanghai 200071, P.R. China, College of Clinical Medicine, Shanghai Hospital of Traditional Chinese Medicine, Shanghai 200071, P.R. China
Published online on: October 1, 2018 https://doi.org/10.3892/ijmm.2018.3904
Pages: 3171-3180
Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Primary colon adenocarcinoma is responsible for high rates of mortality worldwide. The late diagnosis and lack of reliable biomarkers and therapeutic targets forms a bottleneck in the treatment of colon cancer. In the present study, the therapeutic potential of an important microRNA (miR), namely miR‑145, was investigated in primary colon adenocarcinoma cells. The results revealed that the expression of miR‑145 was significantly (P<0.05) downregulated in colon adenocarcinoma cells and the ectopic expression of miR‑145 in colon cancer inhibited proliferation by promoting the apoptosis of SW480 primary colon adenocarcinoma cells. Furthermore, bioinformatics analysis revealed that miR‑145 exerts its effected by targeting mitogen‑activated protein kinase (MAPK) in SW480 cells. This was confirmed by expression analysis wherein the expression of MAPK1 was significantly (P<0.05) upregulated in the primary colon adenocarcinoma cells and the ectopic expression of miR‑145 inhibited the expression of MAPK1. By contrast, the silencing of MAPK1 had similar effects on the proliferation, migration and invasion of SW480 cells as that of the overexpression of miR‑145. Furthermore, it was observed that the inhibition of miR‑145 did not reverse the effects of MAPK1 silencing on SW480 cells. However, the overexpression of MAPK1 led to considerable reversal of the effects of the overexpression of miR‑145 on the proliferation, migration and invasion of SW480 cells. The effects of the overexpression of miR‑145 were also evaluated in vivo in xenografted mice and it was observed that the overexpression of miR‑145 also inhibited tumor growth and volume in vivo. Taken together, it was concluded that miR‑145 may prove to be an important therapeutic target for colon cancer.

View Figures

View References

1	Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, et al: MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. Jama. 299:425–436. 2008. View Article : Google Scholar : PubMed/NCBI
2	Hanif R, Qiao L, Shiff SJ and Rigas B: Curcumin, a natural plant phenolic food additive, inhibits cell proliferation and induces cell cycle changes in colon adenocarcinoma cell lines by a prostaglandin-independent pathway. J Lab Clin Med. 130:576–584. 1997. View Article : Google Scholar
3	Hong J, Lu H, Meng X, Ryu JH, Hara Y and Yang CS: Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (-)-epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells. Cancer Res. 62:7241–7246. 2002.PubMed/NCBI
4	Tsukuda K, Tanino M, Soga H, Shimizu N and Shimizu K: A novel activating mutation of the K-ras gene in human primary colon adenocarcinoma. Biochem Biophys Res Commun. 278:653–658. 2000. View Article : Google Scholar : PubMed/NCBI
5	Ambros V: The functions of animal microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
6	Bartel DP: MicroRNAs: Target recognition and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
7	Esquela-Kerscher A and Slack FJ: Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006. View Article : Google Scholar : PubMed/NCBI
8	Ji W, Sun B and Su C: Targeting microRNAs in cancer gene therapy. Genes (Basel). 8. pii; pp. E212017, View Article : Google Scholar
9	Sachdeva M and Mo YY: miR-145-mediated suppression of cell growth, invasion and metastasis. Am J Transl Res. 2:170–180. 2010.PubMed/NCBI
10	Fei B and Wu H: MiR-378 inhibits progression of human gastric cancer MGC-803 cells by targeting MAPK in vitro. Oncol Res. 20:557–564. 2013. View Article : Google Scholar
11	Steibel JP, Poletto R, Coussens PM and Rosa GJ: A powerful and flexible linear mixed model framework for the analysis of relative quantification RT-PCR data. Genomics. 94:146–152. 2009. View Article : Google Scholar : PubMed/NCBI
12	Vidya Priyadarsini R, Senthil Murugan R, Maitreyi S, Ramalingam K, Karunagaran D and Nagini S: The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and NF-κB inhibition. Eur J Pharmacol. 649:84–91. 2010. View Article : Google Scholar : PubMed/NCBI
13	Kasibhatla S, Amarante-Mendes GP, Finucane D, Brunner T, Bossy-Wetzel E and Green DR: Acridine orange/ethidium bromide (AO/EB) staining to detect apoptosis. CSH Protoc. 2006:pii:pdb-rot44932006.
14	Wang Y, Zhao W and Fu Q: miR-335 suppresses migration and invasion by targeting ROCK1 in osteosarcoma cells. Mol Cell Biochem. 384:105–111. 2013. View Article : Google Scholar : PubMed/NCBI
15	Gotham SM, Fryer PJ and Paterson WR: The measurement of insoluble proteins using a modified Bradford assay. Anal Biochem. 173:353–358. 1988. View Article : Google Scholar : PubMed/NCBI
16	Fhaner CJ, Liu S, Ji H, Simpson RJ and Reid GE: Comprehensive lipidome profiling of isogenic primary and metastatic colon adenocarcinoma cell lines. Anal Chem. 84:8917–8926. 2012. View Article : Google Scholar : PubMed/NCBI
17	Bushati N and Cohen SM: microRNA functions. Annu Rev Cell Dev Biol. 23:175–205. 2007. View Article : Google Scholar : PubMed/NCBI
18	Alvarez-Garcia I and Miska EA: MicroRNA functions in animal development and human disease. Development. 132:4653–4662. 2005. View Article : Google Scholar : PubMed/NCBI
19	Gao S, Wang P, Hua Y, Xi H, Meng Z, Liu T, Chen Z and Liu L: ROR functions as a ceRNA to regulate Nanog expression by sponging miR-145 and predicts poor prognosis in pancreatic cancer. Oncotarget. 7:1608–1618. 2016.
20	Yin R, Zhang S, Wu Y, Fan X, Jiang F, Zhang Z, Feng D, Guo X and Xu L: microRNA-145 suppresses lung adenocarcinoma-initiating cell proliferation by targeting OCT4. Oncol Rep. 25:1747–1754. 2011.PubMed/NCBI
21	Arndt GM, Dossey L, Cullen LM, Lai A, Druker R, Eisbacher M, Zhang C, Tran N, Fan H, Retzlaff K, et al: Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer. BMC Cancer. 9:3742009. View Article : Google Scholar : PubMed/NCBI
22	Fang JY and Richardson BC: The MAPK signalling pathways and colorectal cancer. Lancet Oncol. 6:322–327. 2005. View Article : Google Scholar : PubMed/NCBI
23	Li XW, Tuergan M and Abulizi G: Expression of MAPK1 in cervical cancer and effect of MAPK1 gene silencing on epithelial-mesenchymal transition, invasion and metastasis. Asian Pac J Trop Med. 8:937–943. 2015. View Article : Google Scholar : PubMed/NCBI
24	Lwin WW, Park K, Wauson M, Gao Q, Finn PW, Perkins D and Khanna A: Systems biology approach to transplant tolerance: Proof of concept experiments using RNA interference (RNAi) to knock down hub genes in Jurkat and HeLa cells in vitro. J Surg Res. 176:e41–e462012. View Article : Google Scholar : PubMed/NCBI
25	Li XW, Tuergan M and Abulizi G: Expression of MAPK1 in cervical cancer and effect of MAPK1 gene silencing on epithelial mesenchymal transition, invasion and metastasis. Asian Pac J Trop Med. 8:937–943. 2015. View Article : Google Scholar : PubMed/NCBI